Hypertensive crisis resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 29: Line 29:
{{familytree | | | | B01 | | |B01=<div style="float: left; text-align: left; height: 17em; width: 40em; padding:1em;">'''Examine the patient:'''
{{familytree | | | | B01 | | |B01=<div style="float: left; text-align: left; height: 17em; width: 40em; padding:1em;">'''Examine the patient:'''
----
----
❑ [[Blood pressure]] <br>♦ Measured by the physician <br>♦ Both arms <br>♦ Appropriate cuff size <br>❑ [[Fundoscopy|Fundoscopic exam]] (looking for [[papilledema]], [[exudates]], [[hemorrhage]]s)<br> Complete neurological  and [[mental status]] exam<br>❑ Cardiopulmonary signs of [[pulmonary edema]], [[murmur]]s, gallops<br>❑ Abdomen (looking for pulsatile masses, tenderness, bruits)<br>❑  Peripheral [[pulse]]s</div>}}
❑ [[Blood pressure]] <br>♦ Measured by the physician <br>♦ Both arms <br>♦ Appropriate cuff size <br>❑ [[Fundoscopy|Fundoscopic exam]] (looking for [[papilledema]], [[exudates]], [[hemorrhage]]s)<br>Complete neurological  and [[mental status]] exam<br>❑ Cardiopulmonary signs of [[pulmonary edema]], [[murmur]]s, gallops<br>❑ Abdomen (looking for pulsatile masses, tenderness, bruits)<br>❑  Peripheral [[pulse]]s</div>}}
{{familytree | | | | |!| | | | | |}}
{{familytree | | | | |!| | | | | |}}
{{familytree | | | | C01 | | | |C01=<div style="float: left; text-align: left; height: 30em; width: 40em; padding:1em;">'''Order Labs:'''<br> ❑ [[CBC]]<br>
{{familytree | | | | C01 | | | |C01=<div style="float: left; text-align: left; height: 30em; width: 40em; padding:1em;">'''Order Labs:'''<br> ❑ [[CBC]]<br>

Revision as of 16:50, 24 January 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2] Rim Halaby, M.D. [3]

Definitions

  • Hypertensive urgency is the severe elevation in the blood pressure (systolic blood pressure>160 mmHg, or diastolic blood pressure>100 mmHg) with no or minimal evidence of acute target organ damage.[1]

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. Hypertensive crisis is a life-threatening condition and must be treated as such irrespective of the cause.

Common Causes

Management

 
 
 
Characterize the symptoms:

CNS: severe headache, dizziness, confusion, weakness/numbness, dysphagia, altered level of consciousness
Eyes: pain, blurred/loss of vision
Cardiopulmonary: chest pain, dyspnea
Renal: hematuria, proteinuria, reduced urinary output
Other: nausea, vomiting, anxiety, nosebleeds

Obtain a detailed history:


❑ Past medical history of HTN
❑ Use of medications (prescription or over the counter)
❑ Compliance to anti-hypertensive medications if applicable
❑ Recreational drug use (methamphetamine, cocaine, phencyclidine)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:
Blood pressure
♦ Measured by the physician
♦ Both arms
♦ Appropriate cuff size
Fundoscopic exam (looking for papilledema, exudates, hemorrhages)
❑ Complete neurological and mental status exam
❑ Cardiopulmonary signs of pulmonary edema, murmurs, gallops
❑ Abdomen (looking for pulsatile masses, tenderness, bruits)
❑ Peripheral pulses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Order Labs:
CBC

Electrolytes
BUN
Creatinine
EKG (in case of chest pain)
CXR ( in case of chest pain or dyspnea)
CT or MRI (in case of suspicion of aortic dissection)


Consider additional tests based on each patient's presentation:[2]

❑ Urine electrolytes, creatinine, protein CT/MRI
❑ Renal ultrasound + doppler TSH, free T3, free T4
❑ Serum cortisol ❑ Serum aldosterone
❑ Serum renin ❑ 24-hr urinary catecholamine & metanephrine
❑ Serum parathyroid hormone ❑ Urine and serum toxicology screen
❑ Urine pregnancy test ANA/ESR/CRP/anti-dsDNA/anti-smith/rheumatoid factor/p-ANCA/c-ANCA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evidence of end organ damage
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YES
 
 
 
NO
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypertensive emergency
(NB - Treat the patient and not the BP)
 
 
 
Hypertensive urgency
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Admit to ICU[3]
Close BP monitoring

Intra-arterial BP monitoring in severely-ill patients

Assess volume status - IV N/S if volume depleted to prevent precipitous fall in BP following administration of antihypertensives

Commence continuous infusion of short acting IV antihypertensives based on patient's end organ damage

Change IV meds to oral when BP is stable
NB - Not more than 25% reduction in BP within the 1st hour; when BP is stable, reduce to 160/100-110 mmHg within the next 2-6 hours
When the patient is stable and the blood pressure is well tolerated, reduce the blood pressure to normal within 24-48 hours
 
 
 
Outpatient/Admit for observation
Oral antihypertensives
Clinical surveillance within the first few hours of commencing medications
NB - Gradual BP reduction over 24 - 48 hours
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Management of specific hypertensive emergencies
 
Failure to control the blood pressure
❑ Consider combination of antihypertensives
 
Good control of the blood pressure
❑ Review old/start new medication
❑ Modify risk factors
❑ Schedule a follow up
 

Intravenous Antihypertensives

Shown below is a table of the IV antihypertensive drugs and their appropriate doses.[4]

Drug Dose
Clevidipine 1 to 2 mg/h as IV infusion, max 16 mg/h
Enalaprilat 1.25–5 mg every 6 hrs IV
Fenoldopam 0.1–0.3 µg/kg per min IV infusion
Hydralazine 10–20 mg IV
Nicardipine 5–15 mg/h IV
Nitroglycerin 5–100 µg/min as IV infusion
Nitroprusside 0.25–10 µg/kg/min as IV infusion
Esmolol 250–500 µg/kg/min IV bolus, then 50–100 µg/kg/min by infusion
May repeat bolus after 5 min or increase infusion to 300 µg/min
Labetalol 20–80 mg IV bolus every 10 min 0.5–2.0 mg/min IV infusion
Phentolamine 5–15 mg IV bolus

Oral Antihypertensives

Drug Dose
Captopril 12.5 to 25 mg PO or SL, repeat as needed. max dose - 50 mg PO
Clonidine 0.1-0.2 mg PO x 1, then 0.05 to 0.1 mg/1-2 hrs. Max dose - 0.6 to 0.7 mg
Labetalol 200 mg PO, then 200 mg/hr until desired effect. Max dose - 1200 mg
  • Other agents to consider include:
  1. PO frusemide 20mg (repeat as necessary)
  2. PO nifedipine SR 30mg, single dose
  3. PO felodipine 5 mg, single dose

Management of Specific Hypertensive Emergencies

Hypertensive emergencies Preferred agents
Aortic dissection Labetalol, or nicardipine + esmolol, or nitroprusside + esmolol or nitroprusside + IV metoprolol
Note: Administer beta blocker to control the heart rate before initiating a vasodilator e.g. nitroprusside
  • Reduce BP to 120 mmHg within 20 minutes with protection against reflex tachycardia.[1]
Acute pulmonary edema/systolic dysfunction NTG + (Nicardipine or, fenoldopam, or nitroprusside) + loop diuretic
Acute pulmonary edema/diastolic dysfunction Low-dose NTG + (esmolol, metoprolol, labetalol, or verapamil) + loop diuretic
Acute coronary syndrome NTG + (labetalol or esmolol)
Hypertensive emergency with ARF/CRF Nicardipine or fenoldopam
Hypertensive encephalopathy Nicardipine, labetalol, fenoldopam
Note: The BP should not be lowered by more than 25%
Pre-eclampsia/eclampsia Labetalol or nicardipine
Sympathetic crisis/cocaine overdose Benzodiazepine + (verapamil, diltiazem, or nicardipine)
Note: Beta blockers should NOT be administered alone to prevent un-opposed alpha-adrenergic stimulation
Cerebrovascular accident Nicardipine, labetalol, fenoldopam, or clevidipine
Note: An expert's judgement is required to determine if the BP should be lowered.
Withdrawal of antihypertensive therapy e.g. clonidine or propanolol Re-administer the discontinued drug; phentolamine, nitroprusside, or labetalol, if necessary

Dos

  • Hypertensive emergencies are best managed with a continuous infusion of short-acting titratable antihypertensive agents.
  • Both sublingual and intramuscular routes of drug administration should be avoided due to their unpredictable pharmacodynamics.
  • Assess patients' volume status before commencing intravenous vasodilators to prevent/minimize precipitous fall in blood pressure.[5]

Don'ts

  • Don't consider nifedipine, nitroglycerin and hydralazine as first-line therapies in the management of hypertensive crises due to their potential toxicities and adverse effects.[3]
  • Don't use intramuscular or sublingual antihypertensive medications in the case of hypertensive emergency.
  • Don't use rapid acting antihypertensive if the patient is not in an ICU setting.

References

  1. 1.0 1.1 1.2 Chobanian, AV.; Bakris, GL.; Black, HR.; Cushman, WC.; Green, LA.; Izzo, JL.; Jones, DW.; Materson, BJ.; Oparil, S. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199. Unknown parameter |month= ignored (help)
  2. Varon J, Marik PE (2003). "Clinical review: the management of hypertensive crises". Crit Care. 7 (5): 374–84. doi:10.1186/cc2351. PMC 270718. PMID 12974970.
  3. 3.0 3.1 Varon, J. (2008). "Treatment of acute severe hypertension: current and newer agents". Drugs. 68 (3): 283–97. PMID 18257607.
  4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL; et al. (2003). "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report". JAMA. 289 (19): 2560–72. doi:10.1001/jama.289.19.2560. PMID 12748199.
  5. Marik, PE.; Varon, J. (2007). "Hypertensive crises: challenges and management". Chest. 131 (6): 1949–62. doi:10.1378/chest.06-2490. PMID 17565029. Unknown parameter |month= ignored (help)

Template:WH Template:WS